Life sciences in New England
Bioreactors
From The New England Council (newenglandcouncil.com):
On Tuesday, April 7, 2020, The New England Council will host the sixth event it its popular “New England Innovates” series. “New England Innovates: On the Cutting Edge of Life Sciences,” will feature keynote remarks from Udit Batra, CEO of MilliporeSigma. Headquartered in Burlington, Mass., MilliporeSigma is the life sciences business of Merck KGaA, which develops and manufactures products focused on scientific discovery, biomanufacturing and testing services.
Following Dr. Batra’s remarks, a panel of NEC members representing a diverse array of life sciences businesses and organizations in the region will highlight some of the incredible innovation taking place right here in New England, and will discuss some of the key challenges as well as opportunities for continued growth in this thriving industry.
Launched in 2016, “New England Innovates” is a periodic series presented by The New England Council to promote an ongoing dialogue in the region about how we maintain our reputation as a global innovation hub. Each event focuses on a specific sector or issue affecting innovation in the region, and highlights the role that New England Council members are playing to drive innovation across various sectors of the economy. The goal of each forum is to explore challenges and opportunities for continued innovation and growth, and to examine how policy makers at the local, state, and federal level can support innovation in New England. Past programs have explored such topics as cybersecurity, FinTech, autonomous vehicles, and workforce development.
“New England Innovates: On the Cutting Edge of Life Sciences” will take place at The Hampshire House in Boston on Tuesday, April 7, 2020, from 8:00 a.m. to 10:00 a.m. For more information, contact Emily Heisig at eheisig@newenglandcouncil.com or Sean Malone at smmalone@newenglandcouncil.com.